Hyphens Pharma International Limited (SGX:1J5)
0.3500
0.00 (0.00%)
At close: Oct 31, 2025
SGXC:1J5 Revenue
Hyphens Pharma International had revenue of 44.77M SGD in the quarter ending June 30, 2025, a decrease of -13.32%. This brings the company's revenue in the last twelve months to 185.32M, down -5.22% year-over-year. In the year 2024, Hyphens Pharma International had annual revenue of 195.42M with 14.55% growth.
Revenue (ttm)
185.32M
Revenue Growth
-5.22%
P/S Ratio
0.58
Revenue / Employee
398.53K
Employees
474
Market Cap
108.10M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 195.42M | 24.83M | 14.55% |
| Dec 31, 2023 | 170.60M | 8.28M | 5.10% |
| Dec 31, 2022 | 162.32M | 36.43M | 28.94% |
| Dec 31, 2021 | 125.88M | 4.91M | 4.06% |
| Dec 31, 2020 | 120.98M | 1.54M | 1.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wilmar International | 88.29B |
| Jardine Matheson Holdings | 45.30B |
| DBS Group Holdings | 22.10B |
| Singapore Airlines | 19.54B |
| Singapore Telecommunications | 14.13B |
| Oversea-Chinese Banking Corporation | 13.72B |
| United Overseas Bank | 13.32B |
| Singapore Technologies Engineering | 11.67B |